Literature DB >> 16837466

Cyclic phosphatidic acid is produced by autotaxin in blood.

Satomi Tsuda1, Shinichi Okudaira, Keiko Moriya-Ito, Chie Shimamoto, Masayuki Tanaka, Junken Aoki, Hiroyuki Arai, Kimiko Murakami-Murofushi, Tetsuyuki Kobayashi.   

Abstract

Cyclic phosphatidic acid (cPA), an analog of lysophosphatidic acid (LPA), was previously identified in human serum. Although cPA possesses distinct physiological activities not elicited by LPA, its biochemical origins have scarcely been studied. In the present study, we assayed cPA formation from lysophosphatidylcholine in fetal bovine serum and found significant activity of transphosphatidylation that generated cPA. The cPA-producing enzyme was purified from fetal bovine serum using five chromatographic steps yielding a 100-kDa protein with cPA biosynthetic activity. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of its tryptic peptides revealed that the enzyme shared identical fragments with human autotaxin, a serum lysophospholipase D that produces LPA. Western blot analysis demonstrated that the 100-kDa protein was specifically recognized by an anti-human autotaxin antibody. Moreover, recombinant rat autotaxin was found to generate cPA in addition to LPA. No significant cPA- or LPA-producing activity was detected in autotaxin-depleted serum from bovine or human prepared by immunoprecipitation with an anti-autotaxin monoclonal antibody. These results indicate that the generation of cPA and LPA in serum is mainly attributed to autotaxin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16837466     DOI: 10.1074/jbc.M602925200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

Review 1.  Phospholipase D: enzymology, functionality, and chemical modulation.

Authors:  Paige E Selvy; Robert R Lavieri; Craig W Lindsley; H Alex Brown
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

2.  Synthesis and pharmacological evaluation of the stereoisomers of 3-carba cyclic-phosphatidic acid.

Authors:  Renuka Gupte; Anjaih Siddam; Yan Lu; Wei Li; Yuko Fujiwara; Nattapon Panupinthu; Truc-Chi Pham; Daniel L Baker; Abby L Parrill; Mari Gotoh; Kimiko Murakami-Murofushi; Susumu Kobayashi; Gordon B Mills; Gabor Tigyi; Duane D Miller
Journal:  Bioorg Med Chem Lett       Date:  2010-10-08       Impact factor: 2.823

3.  Lysophosphatidic acids are new substrates for the phosphatase domain of soluble epoxide hydrolase.

Authors:  Ami Oguro; Susumu Imaoka
Journal:  J Lipid Res       Date:  2012-01-03       Impact factor: 5.922

Review 4.  Cellular function and molecular structure of ecto-nucleotidases.

Authors:  Herbert Zimmermann; Matthias Zebisch; Norbert Sträter
Journal:  Purinergic Signal       Date:  2012-05-04       Impact factor: 3.765

5.  Benzyl and naphthalene methylphosphonic acid inhibitors of autotaxin with anti-invasive and anti-metastatic activity.

Authors:  Renuka Gupte; Renukadevi Patil; Jianxiong Liu; Yaohong Wang; Sue C Lee; Yuko Fujiwara; James Fells; Alyssa L Bolen; Karin Emmons-Thompson; C Ryan Yates; Anjaih Siddam; Nattapon Panupinthu; Truc-Chi T Pham; Daniel L Baker; Abby L Parrill; Gordon B Mills; Gabor Tigyi; Duane D Miller
Journal:  ChemMedChem       Date:  2011-04-04       Impact factor: 3.466

6.  Autotaxin regulates vascular development via multiple lysophosphatidic acid (LPA) receptors in zebrafish.

Authors:  Hiroshi Yukiura; Kotaro Hama; Keita Nakanaga; Masayuki Tanaka; Yoichi Asaoka; Shinichi Okudaira; Naoaki Arima; Asuka Inoue; Takafumi Hashimoto; Hiroyuki Arai; Atsuo Kawahara; Hiroshi Nishina; Junken Aoki
Journal:  J Biol Chem       Date:  2011-10-04       Impact factor: 5.157

Review 7.  Lysophosphatidic acid signaling in airway epithelium: role in airway inflammation and remodeling.

Authors:  Yutong Zhao; Viswanathan Natarajan
Journal:  Cell Signal       Date:  2008-10-26       Impact factor: 4.315

Review 8.  Aiming drug discovery at lysophosphatidic acid targets.

Authors:  Gabor Tigyi
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

Review 9.  Therapeutic potential of autotaxin/lysophospholipase d inhibitors.

Authors:  Lorenzo Federico; Zehra Pamuklar; Susan S Smyth; Andrew J Morris
Journal:  Curr Drug Targets       Date:  2008-08       Impact factor: 3.465

Review 10.  Autotaxin.

Authors:  Jean A Boutin; Gilles Ferry
Journal:  Cell Mol Life Sci       Date:  2009-06-09       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.